Abstract
Clinical epidemiology is the science of human disease investigation with a focus on diagnosis, prognosis, and treatment. The generation of a reasonable question requires the definition of patients, interventions, controls, and outcomes. The goal of research design is to minimize error, ensure adequate samples, measure input and output variables appropriately, consider external and internal validities, limit bias, and address clinical as well as statistical relevance. The hierarchy of evidence for clinical decision making places randomized controlled trials (RCT) or systematic review of good quality RCTs at the top of the evidence pyramid. Prognostic and etiologic questions are best addressed with longitudinal cohort studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Chertow, G. M., Moe S. M. (2005) Calcification or classification? J Am Soc Nephrol 16, 293–295.
2. Daugirdas, J. T., Depner, T. A., Gotch, F. A., et al. (1997) Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int 52, 1395–1405.
3. Wright, J. T., Jr., Kusek, J. W., Toto, R. D., et al. (1996) Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials 17, 3S–16S.
4. Thorpe, L. E., Gwynn, R. C., Mandel-Ricci, J., et al. (2006) Study design and participation rates of the New York City Health and Nutrition Examination Survey. Prev Chronic Dis 3, A94.
5. Robbins, J. M., Vaccarino, V., Zhang, H., Kasl, S. V. (2000) Excess type 2 diabetes in African-American women and men aged 40–74 and socioeconomic status: Evidence from the Third National Health and Nutrition Examination Survey. J Epidemiol Community Health 54, 839–845.
6. Julious, S. A. (2004) Sample sizes for clinical trials with normal data. Stat Med 23, 1921–1986.
7. Eknoyan, G., Hostetter, T., Bakris, G. L., et al. (2003) Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute Of Diabetes And Digestive And Kidney Diseases (NIDDK). Am J Kidney Dis 42, 617–622.
8. Manns, B., Owen, W. F., Jr., Winkelmayer, W. C., Devereaux, P. J., Tonelli, M., (2006) Surrogate markers in clinical studies: Problems solved or created? Am J Kidney Dis 48, 159–166.
9. Viera, A. J., Bangdiwala, S. I. (2007) Eliminating bias in randomized controlled trials: Importance of allocation concealment and masking. Fam Med 39, 132–137.
www.cebm.net/levels_of_evidence.asp, last accessed March 23, 2007.
11. Sibbald, B., Roberts, C. (1998) Understanding controlled trials: Crossover trials. BMJ 316,1719.
12. Antman, E. M., Grudzien, C., Sacks, D. B. (1995) Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA 273, 1279–1282.
13. Sackett, D. L., Haynes, R. B., Guyatt, G. H., Tugwell, P. (1991) The interpretation of diagnostic data, in (Sackett, D. L., Haynes, R. B., Guyatt, G. H., Tugwell, P., eds.) Clinical Epidemiology, a Basic Science for Clinical Medicine. Little, Brown and Company, Toronto, Canada, pp. 117–119.
14. Alp, N. J., Bell, J. A., Shahi, M. (2001) A rapid troponin-I-based protocol for assessing acute chest pain. Q J Med 94, 687–694.
15. Moher, D., Schulz, K. F., Altman, D. G., for the CONSORT Group. (2001) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 357, 1191–1194.
www.strobe-statement.org, last accessed March 23, 2007.
www.consort-statement.org/stardstatement.htm, last accessed March 23, 2007.
18. Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., Stroup, D. F., for the QUOROM Group. (1999) Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement. Lancet 354, 1896–900.
Ravani, P., Parfrey, P. S., Curtis, B., Barrett, B.J. (2007) Clinical research of kidney diseases, I: Researchable questions and valid answers. Nephrol Dial Transpl 22, 3681–3690.
Ravani, P., Parfrey, P. S., Dicks, E., Barrett, B.J. (2007) Clinical research of kidney diseases, II: Problems of research design. Nephrol Dial Transpl 22, 2785–2794.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Parfrey, P., Ravani, P. (2008). On Framing the Research Question and Choosing the Appropriate Research Design. In: Barrett, B., Parfrey, P. (eds) Clinical Epidemiology. Methods in Molecular Biology™, vol 473. Humana Press. https://doi.org/10.1007/978-1-59745-385-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-385-1_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-964-2
Online ISBN: 978-1-59745-385-1
eBook Packages: Springer Protocols